Protoporphyrin (PpIX), a porphyrin derivative, is the intermediate metabolic precursor of the heme molecule. Abnormal metabolism of total erythrocyte PpIX has been observed in diseases such as cancer, lead poisoning, psoriasis, iron deficiency anemia and acute porphyries. Diabetes mellitus (DM) is a complex metabolic syndrome in which hyperglycemia is the primary clinical manifestation and contributes to the diabetic complications. The aim of this study was to evaluate the utility of fluorescence spectroscopy of erythrocyte PpIX for monitoring the early stages of diabetes. A total of 14 male C 57BL mice, 6 weeks old, were divided into two groups: diabetic and non-diabetic. Diabetes was induced by intraperitoneal injection of streptozotocin (SZT). Blood cells were cultured with standard and 50 mM supplemented RPMI medium. Blood smears were prepared and stained for qualitative morphology analysis under optical microscopy. Blood porphyrin autofluorescence was analyzed by fluorescence spectroscopy. Characteristic PpIX emission spectra were obtained by exciting the samples at 405 nm. Average blood glucose was lower in the control group than in the diabetic group (156.50 +/- 8.11 mg/dL vs. 371.10 +/- 14.43 mg/dL, P < 0.05). Both diabetic and glucose-cultured erythroblasts showed a significant decrease (around 30.5% and 40%, respectively) in the emission band intensity at 635 nm. Our results indicate that the erythrocyte PpIX profile could be used as a biological monitor for diabetes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1366/000370210791114248 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Low-Cost, Portable, Multi-Cancer Screening Device Based on a Ratio Fluorometry and Signal Correlation Technique.
Biosensors (Basel)
October 2024
Department of Electrical and Computer Engineering, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
The autofluorescence of erythrocyte porphyrins has emerged as a potential method for multi-cancer early detection (MCED). With this method's dependence on research-grade spectrofluorometers, significant improvements in instrumentation are necessary to translate its potential into clinical practice, as with any promising medical technology. To fill this gap, in this paper, we present an automated ratio porphyrin analyzer for cancer screening (ARPA-CS), a low-cost, portable, and automated instrument for MCED via the ratio fluorometry of porphyrins.
View Article and Find Full Text PDFErythropoietic protoporphyrias: Pathogenesis, diagnosis and management.
Liver Int
January 2025
Department of Internal Medicine, Porphyria Center Rotterdam, Center for Lysosomal and Metabolic Disease, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Article Synopsis
- The erythropoietic protoporphyrias are three rare genetic disorders that disrupt heme production, causing a buildup of protoporphyrin IX (PPIX) in red blood cells and leading to severe skin pain from light exposure, starting in early childhood.
- Diagnosis involves measuring PPIX levels in the blood, and complications can include liver issues, gallstones, anemia, and vitamin D deficiency.
- Management focuses on avoiding light triggers, addressing complications, and using treatments like afamelanotide to improve quality of life, with careful consideration of iron supplementation depending on the specific disorder.
Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature.
World J Hepatol
June 2024
Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong Province, China.
Article Synopsis
- Erythropoietic protoporphyria (EPP) is a genetic disorder caused by mutations in the ferrochelatase gene, leading to a harmful build-up of protoporphyrin IX mainly affecting blood cells, skin, and the liver.
- A case study of a 35-year-old male with liver issues due to EPP showed that combining red blood cell exchange and therapeutic plasma exchange significantly improved his symptoms and lowered bilirubin levels.
- The results indicate that this combined treatment approach may be a promising option for managing severe liver impairment in patients with EPP.
Erythropoietic protoporphyrias: updates and advances.
Trends Mol Med
September 2024
Institut National de la Santé et de la Recherche Médicale U1149, Centre de Recherche sur l'Inflammation, Paris, France; Université Paris Cité, Paris, France; Assistance Publique-Hôpitaux de Paris, Centre de Référence Maladies Rares Porphyries, Hôpital Louis Mourier, Colombes, France; Laboratory of excellence Gr-Ex, Paris, France.
Article Synopsis
- Protoporphyrias are genetic disorders caused by mutations in enzymes that produce heme, leading to the buildup of a toxic compound called protoporphyrin (PPIX) in red blood cells.
- This accumulation causes severe skin sensitivity to light, greatly affecting patients' quality of life, and can also increase the risk of liver disease.
- Current treatments are limited and focus mainly on supportive care, but new therapeutic strategies are being explored in clinical trials that might significantly improve management of the disease in the future.
Effects of iron supplements in individuals with erythropoietic protoporphyria.
Photodiagnosis Photodyn Ther
June 2024
Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark.
Article Synopsis
- Protoporphyrin IX (PPIX) is a key precursor for heme production, and individuals with erythropoietic protoporphyrias (EPP) struggle with PPIX accumulation that leads to photosensitivity and liver disease risks, often coupled with iron deficiency.
- A systematic review of literature revealed limited previous studies, and a follow-up investigation involved 10 EPP patients taking oral iron supplements to assess changes in PPIX levels and hemoglobin.
- Results showed that most patients experienced increased PPIX levels, some improvement in hemoglobin, and minor liver enzyme elevation, indicating that iron supplementation can benefit EPP patients but requires careful monitoring of their condition.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!